ClinicalTrials.gg
CompletedNCT06800911METAOBESUpdated Nov 10, 2026

Metacognitive Beliefs in Obese Patients

An observational study in Obesity, sponsored by Istituto Auxologico Italiano. Completed at 1 site in Italy. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Istituto Auxologico Italiano · Observational

How we know

Updated Nov 10, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
90
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 42 studies in Obesity by Istituto Auxologico Italiano — 11 open to participants now, 12 under way, none of them phase 3. Obesity · Istituto Auxologico Italiano.

Enrollment
8th of 20
90 · median 80
Started
2024
with 2 others
Observational
20 of 42
5 open now
Registered
38th of 42
by date

Among the 42 studies in Obesity by Istituto Auxologico Italiano, this one is the 8th largest by enrollment of the 20 observational ones that give a count, is one of 3 that started in 2024, is one of 20 observational ones, and was the 38th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

11 of the 42 studies in Obesity by Istituto Auxologico Italiano are open now, in 1 country. Recruiting first, the newest first:

6 more — sign in →

By country, each count listing its studies:

All 11 open studies →

Where they have run

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 42 studies in Obesity by Istituto Auxologico Italiano, or all of them as a file.
02

Study summary

The study aims to investigate the presence of metacognitive beliefs, emotional regulation, and emotional eating in obese patients and their possible relationships.

03

Conditions studied

  • Obesity

Browse trials for

Keywords

  • Metabeliefs
  • Metacognition
  • Rumination
  • Dysfunctional lifestyle
  • Rehabilitation
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

90 patients aged between 18 and 65, of both sexes, of Italian nationality, suffering from obesity (Body Mass Index, BMI: kg/m2 ≥ 35, according to the criteria of the World Health Organization WHO).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age: between 18 and 65 years
  • Italian nationality
  • ≥ 35 kg/m2

Exclusion criteria

Exclusion Criteria:

  • Psychiatric pathologies
  • Severe cognitive deficits that could compromise the completion of the questionnaires
  • Absence of signed
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
90 participants (actual)
Patient registry
No

Groups and cohorts

  • Obesity

    Patients aged between 18 and 65, of both sexes, of Italian nationality, suffering from obesity (Body Mass Index, BMI: kg/m2 ≥ 35, according to the criteria of the World Health Organization WHO).

    Other: Questionnaires

Interventions

  • OtherQuestionnaires

    Metacognition Questionnaire Penn State Worry Questionnaire Ruminative Response Scale Anger Rumination scale Difficulties in Emotion Regulation Scale Emotional Eating subscale of the Dutch Eating Behavior Questionnaire

06

What researchers measure

Primary outcomes

  1. Metacognitive beliefs

    Metacognition Questionnaire (MCQ-30) is a self-report test composed of 30 items on a 4-point Likert scale from 1 (I do not agree) to 4 (I completely agree agreement).

    Time frame: Baseline

  2. Rumination

    Ruminative Response Scale (RRS) is a self-report test composed of 20 items on a 4-point Likert scale from 1 (almost never) to 4 (almost always).

    Time frame: Baseline

  3. Anger Rumination

    Anger Rumination scale (ARS) is a self-report test composed of 14 items, on a Likert scale from 1 (almost never) to 4 (almost always).

    Time frame: Baseline

  4. Emotional dysregulation

    Difficulties in Emotion Regulation Scale (DERS) isa self-report test composed of 36 items on a Likert scale from 1 (almost never) to 5 (almost always).

    Time frame: Baseline

  5. Emotional eating

    Emotional Eating subscale of the Dutch Eating Behavior Questionnaire (DEBQ), composed of 13 items on a Likert scale from 0 (never) to 4 (almost always)

    Time frame: Baseline

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from May 2024 to primary completion in May 2025, 12 months.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 10, 2026: primary completion May 2026 → May 2025 and completion May 2026 → May 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 24, 2025
First posted
Jan 30, 2025
StartActual
May 28, 2024
Primary completionActual
May 31, 2025was May 2026
CompletionActual
May 31, 2025was May 2026
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 10, 2026
Primary completion
May 31, 2026→May 31, 2025 (actual)
Nov 10, 2026
Study completion
May 31, 2026→May 31, 2025 (actual)
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Recruiting→Completed
    Primary completion May 31, 2026→May 31, 2025 (now actual)
    Study completion May 31, 2026→May 31, 2025 (now actual)
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06800911
Responsible party
Sponsor
First posted
Jan 30, 2025
Start date
May 28, 2024
Primary completion
May 31, 2025
Completion
May 31, 2025
Last update
Nov 10, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion